Sign In
Buy NEO
$10.14
+0.0200 (+0.198%)
At Close: Jun 03, 2026
NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients
12:00pm, Tuesday, 05'th May 2020
MYERS, FL / ACCESSWIRE / May 5, 2020 / NeoGenomics, Inc. (NEO), a leading provider of cancer-focused genetic testing services, today announced a collaboration with Bayer (BAYN) to facilitate an RNA-ba
Bayer today announced the launch of Test4TRK™ program in collaboration with NeoGenomics, Inc. to offer genomic cancer testing for NTRK gene fusions at
NEOGENOMICS INC : Entry into a Material Definitive Agreement (form 8-K) | MarketScreener
09:21pm, Monday, 04'th May 2020Q3 2020 Earnings Forecast for NeoGenomics, Inc. (NASDAQ:NEO) Issued By SVB Leerink
08:28am, Saturday, 02'nd May 2020
NeoGenomics, Inc. (NASDAQ:NEO) – Equities research analysts at SVB Leerink cut their Q3 2020 earnings per share (EPS) estimates for shares of NeoGenomics in a report released on Tuesday, April 28th.
Here's Why NeoGenomics Is Tumbling Today
04:07pm, Thursday, 30'th Apr 2020
The company decided to pull the trigger on a combined offering of stock and debt to pad its balance sheet during uncertain times.
Trader: Bitcoin's Current Rally Isn't Corrective, It's Impulsive
03:30pm, Thursday, 30'th Apr 2020
Crypto traders explain why this Bitcoin rally may be more than just a correction
RDS.A, LYG among premarket losers
01:19pm, Thursday, 30'th Apr 2020
Chesapeake Energy (NYSE:CHK) -43% after preparing bankruptcy filing.On Deck Capital (NYSE:ONDK) -19% on Q1 earnings.Capricor Therapeutics (NASDAQ:CAPR) -16%.Capstead Mortgage (NYSE:CMO) -13% on
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
NeoGenomics prices convertible debt and stock offerings
11:04am, Thursday, 30'th Apr 2020
NeoGenomics (NASDAQ:NEO) has priced its public offering of 4.4M common shares at $28.50. Underwriters' over-allotment is an additional 660K shares. Gross proceeds should be $125.4M.The underwriters a
NEOGENOMICS INC : Regulation FD Disclosure (form 8-K) | MarketScreener
10:15am, Thursday, 30'th Apr 2020NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
10:00am, Thursday, 30'th Apr 2020
FORT MYERS, FL / ACCESSWIRE / April 30, 2020 / NeoGenomics, Inc. (NASDAQ:NEO) (the " Company " ), a leading provider of cancer-focused genetics testing services, today announced the pricing of ...
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
12:00am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 29)
• Arvinas Inc (NASDAQ...
Neogenomics Filing Shows Registration For $100M Common Stock Shelf Offering
09:27pm, Wednesday, 29'th Apr 2020NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
09:20pm, Wednesday, 29'th Apr 2020
In addition, NeoGenomics expects to grant the underwriters of the offerings a 30-day option to purchase up to an additional (a) $15,000,000 of shares of its common stock at the public offering price,
Edited Transcript of NEO earnings conference call or presentation 28-Apr-20 12:30pm GMT
12:55pm, Wednesday, 29'th Apr 2020
Q1 2020 Neogenomics Inc Earnings Call
